Pavmed Inc Revenue Growth Rates (PAVM), Current and Historic Growth - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Sales Y/Y Annual
Pavmed Inc   (NASDAQ: PAVM)
 

PAVM's Revenue Growth by Quarter and Year

Pavmed Inc 's Revenue results by quarter and year



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

PAVM Revenue (in millions $) FY 2026 FY 2025 FY 2024 FY 2023
4th Quarter December -
3rd Quarter September -
2nd Quarter June 0.03
1st Quarter March 0.05
FY 0.08

PAVMs Annual Revenue
Pavmed Inc 's Revenue in the fiscal year 2025 $ 0.07 millions
Pavmed Inc 's Revenue in the fiscal year 2024 $ 3.25 millions
Pavmed Inc 's Revenue in the fiscal year 2023 $ 2.96 millions
Pavmed Inc 's Revenue in the fiscal year 2022 $ 0.38 millions
Pavmed Inc 's Revenue in the fiscal year 2021 $ 0.50 millions




PAVM Revenue second quarter 2026 Y/Y Growth Comment
Pavmed Inc achieved in the second quarter 2026, above Company average Revenue surge of 230% year on year, to $ 0.03 millions.

Looking into second quarter 2026 results within Medical Equipment & Supplies industry 6 other companies have achieved higher Revenue growth. While Pavmed Inc ' s Revenue doubling of 230% ranks overall at the positon no. 142 in the second quarter 2026.


PAVM Revenue ( Y/Y Growth %) 2026
 2025 2024 2023
4th Quarter December - 200 % -99.13 % 945.45 %
3rd Quarter September - -98.13 % 16.3 % 1050 %
2nd Quarter June 230 % -99.08 % 230.3 % -
1st Quarter March 150 % -98.15 % 89.47 % 200 %
FY   - -97.54 % 9.43 % -

Financial Statements
Pavmed Inc 's second quarter 2026 Revenue $ 0.03 millions PAVM's Income Statement
Pavmed Inc 's second quarter 2025 Revenue $ 0.01 millions Quarterly PAVM's Income Statement


PAVM Revenue (Quarter on Quarter Growth %)

 2026
 2025 2024 2023
4th Quarter December - 50 % -99.07 % 25 %
3rd Quarter September - 100 % -1.83 % 178.79 %
2nd Quarter June -34 % -50 % 0.93 % -42.11 %
1st Quarter March 66.67 % 100 % -6.09 % 418.18 %
FY (Year on Year)   - -97.54 % 9.43 % -


Back to PAVM Growth rate Comparisons >> Back to PAVM Growth rate Comparisons >>


Revenue second quarter 2026 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #7
Healthcare Sector #44
Overall #142

Revenue Y/Y Growth Statistics
High Average Low
1103.95 % 168.23 % -98.95 %
(Jun 30 2024)   (Sep 30 2025)
Revenue second quarter 2026 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #7
Healthcare Sector #44
Overall #142
Revenue Y/Y Growth Statistics
High Average Low
1103.95 % 168.23 % -98.95 %
(Jun 30 2024)   (Sep 30 2025)

Revenue by Quarter for the Fiscal Years 2023, 2024, 2025, 2026

Pavmed Inc 's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
406.25 % 32.6 % -100 %
(Mar 31 2023)  


PAVM's II. Quarter Q/Q Revenue Comment
In the II. Quarter 2026 Pavmed Inc disclosed fall in Revenue from the first quarter by -34% to $ 0.03 millions, from $ 0.05 millions achived in the previous reporting period.

But that's not important problem, as Pavmed Inc 's Revenue generally seem to plunge in this quarter.

Within Medical Equipment & Supplies industry 171 other companies have achieved higher Revenue quarter on quarter growth. While Pavmed Inc 's Revenue growth quarter on quarter, overall rank is 3553.


Revenue Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #172
Healthcare Sector #505
Overall #3553
Revenue Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #172
Healthcare Sector #505
Overall #3553
Revenue Q/Q Growth Statistics
High Average Low
406.25 % 32.6 % -100 %
(Mar 31 2023)  


PAVM's II. Quarter Q/Q Revenue Comment
In the II. Quarter 2026 Pavmed Inc disclosed fall in Revenue from the first quarter by -34% to $ 0.03 millions, from $ 0.05 millions achived in the previous reporting period.

But that's not important problem, as Pavmed Inc 's Revenue generally seem to plunge in this quarter.

Within Medical Equipment & Supplies industry 171 other companies have achieved higher Revenue quarter on quarter growth. While Pavmed Inc 's Revenue growth quarter on quarter, overall rank is 3553.


Pavmed Inc 's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Jun 30 2026)		 12 Months Ending
(Mar 31 2026)		 12 Months Ending
(Dec 31 2025)		 12 Months Ending
(Sep 30 2025)		 12 Months Ending
(Jun 30 2025)
Cumulative Revenue 12 Months Ending $ 0.13 $ 0.11 $ 0.07 $ 0.06 $ 1.11
Y / Y Revenue Growth (TTM) -88.63 % -95.1 % -97.81 % -98.7 % -73.82 %
Year on Year Revenue Growth Overall Ranking # 3706 # 3195 # 0 # 76 # 40
Seqeuential Revenue Change (TTM) 17.76 % 50.7 % 24.56 % -94.86 % -49.24 %
Seq. Revenue Growth (TTM) Overall Ranking # 3628 # 3163 # 0 # 1668 # 507


Cumulative Revenue growth Comment
Pavmed Inc showed decline, but improvement compare to trailing twelve month Revenue decrease in Mar 31 2026. If the fiscal year would end in Jun 30 2026, Pavmed Inc 's annual Revenue drop would be -88.63% year on year to $0 millions.

In the Healthcare sector 520 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 3195 to 3706.

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 170
Healthcare Sector # 521
Overall # 3706

Revenue TTM Y/Y Growth Statistics
High Average Low
290.41 %
 -7 %
-98.7 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 170
Sector # 496
S&P 500 # 3628
Cumulative Revenue growth Comment
Pavmed Inc showed decline, but improvement compare to trailing twelve month Revenue decrease in Mar 31 2026. If the fiscal year would end in Jun 30 2026, Pavmed Inc 's annual Revenue drop would be -88.63% year on year to $0 millions.

In the Healthcare sector 520 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 3195 to 3706.


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 170
Healthcare Sector # 521
Overall # 3706

Revenue TTM Y/Y Growth Statistics
High Average Low
290.41 %
-7 %
-98.7 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 170
Sector # 496
S&P 500 # 3628




Other Revenue Growth
Medical Equipment & Supplies Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
PAVM's Revenue Growth Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth




Companies with similar Revenue drop for the quarter ending Jun 30 2026 within Healthcare SectorY/Y Change %Revenue for the quarter ending Jun 30 2026
Insmed Inc393.78%$ 393.775 millions
Omeros Corporation387.10%$ 387.096 millions
Catheter Precision Inc 380.66%$ 380.660 millions
Macrogenics Inc 377.97%$ 377.974 millions
Vireo Growth Inc.335.47%$ 335.470 millions
Dianthus Therapeutics Inc 294.30%$ 294.301 millions
Miragen Therapeutics Inc 278.67%$ 278.667 millions
Alpha Cognition Inc.267.56%$ 267.556 millions
Agios Pharmaceuticals Inc 259.25%$ 259.253 millions
Omniab Inc 244.24%$ 244.239 millions
Medicinova Inc 240.60%$ 240.596 millions
Clene Inc 233.33%$ 233.333 millions
Editas Medicine Inc 232.31%$ 232.309 millions
Urogen Pharma Ltd 206.17%$ 206.174 millions
Sintx Technologies Inc 199.34%$ 199.338 millions
Arrowhead Pharmaceuticals Inc 171.02%$ 171.016 millions
Cue Biopharma Inc 166.66%$ 166.655 millions
Qt Imaging Holdings Inc exact Name Of Registrant As Specified In Its Charter _______________________162.99%$ 162.992 millions
Cormedix Inc 156.52%$ 156.515 millions
Ataibeckley Inc 137.00%$ 136.996 millions
Pavmed Inc 135.71%$ 135.714 millions
Xilio Therapeutics Inc 131.22%$ 131.222 millions
Tenon Medical Inc 126.77%$ 126.773 millions
Sonida Senior Living Inc 122.02%$ 122.024 millions
Bridgebio Pharma Inc 120.39%$ 120.392 millions
Autolus Therapeutics Plc118.37%$ 118.367 millions
Neuraxis Inc 115.72%$ 115.717 millions
Renovorx Inc 115.40%$ 115.403 millions


About Pavmed Inc Revenue Growth Rates (PAVM), Current and Historic Growth - CSIMarket Analysis

How we calculate this

This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years). Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.

What’s included here

Company: Pavmed Inc (CIK 1624326).

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings → XBRL parse → normalization CSIMarket.com Database → growth calculations.
  • Accession: 0001437749-26-027733
  • Figures are derived from filed reports and may be restated; numbers are subject to revision.

Sources: Pavmed Inc’s SEC filings (XBRL/Inline XBRL) and CSIMarket.com’s normalization & QA processes.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.